The company shows 59.21 million in cash in most recent quarter with 14.01 million outstanding shares.
Add 37.6 million in cash from recent share sale and add 4.5 million shares sold,you get 96.81 million dollars in cash,and 18.51 million shares.
96.81/18.51 gets you 5.23 dollars cash per share.
This is besides the potential revenue from their new sleep drug on the market,and the current 6.56 price is ridiculous.
Keep dreaming on 2 dollars.
Manny
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM